Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: Clinical Trial of Memantine for Major Depression [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating memantine for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Namenda (memantine)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Depression | Phase 3 | Status: COMPLETED